Wikisage, the free encyclopedia of the second generation, is digital heritage
Brivaracetam: Difference between revisions
Jump to navigation
Jump to search
m (neuropsi dis treat) |
mNo edit summary |
||
| Line 1: | Line 1: | ||
<gallery>File:Brivaracetam3d.png|(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide</gallery> | <gallery>File:Brivaracetam3d.png|(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide</gallery> | ||
4n propyl analog of [[levetiracetam]], this | 4n propyl analog of [[levetiracetam]], this and levetiracetam may have potential in the mangement of progressive myoclonic [[epilepsy|epilepsies]] | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf Profile of brivaracetam and its potential in the treatment of epilepsy]</ref> | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670022/pdf/ndt-11-2967.pdf Profile of brivaracetam and its potential in the treatment of epilepsy]</ref> | ||
Revision as of 01:27, 30 March 2016
-
![(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide](/w/images/thumb/6/64/Brivaracetam3d.png/120px-Brivaracetam3d.png)
(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide
![(2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide](/wiki/File:Brivaracetam3d.png)
4n propyl analog of levetiracetam, this and levetiracetam may have potential in the mangement of progressive myoclonic epilepsies [1]
Links
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm486827.htm
ATC